Vaccine Boom Over? Watch Pfizer’s Earnings to Find Out
Money & Markets Week Ahead for February 1, 2021: Pfizer’s earnings should tell us how profitable COVID-19 vaccine efforts have been.
Posted by Matthew Clark | Jan 31, 2021 | Markets
Money & Markets Week Ahead for February 1, 2021: Pfizer’s earnings should tell us how profitable COVID-19 vaccine efforts have been.
Posted by Matthew Clark | Jan 30, 2021 | Investing, Podcast
The Bull & The Bear crew has three stocks to buy now: Dalek Logistics Partners LP, International Paper Co. and Magna International Inc.
Posted by Matthew Clark | Jan 29, 2021 | Investing
In this episode of my Marijuana Market Update, I take a closer look at Charlotte’s Web Holdings Inc. (OTC: CWBHF) a CBD stock.
Posted by Matthew Clark | Jan 28, 2021 | Investing, Podcast
In this episode of The Bull & The Bear podcast, I tell you why Medifast Inc. (NYSE: MED) stock is worth a spot in your 2021 portfolio.
Posted by Matthew Clark | Jan 26, 2021 | Investing
Tech stocks have driven the market out of the COVID-19 crash. Here’s why Genasys (GNSS) and Turtle Beach (HEAR) are great buys in 2021.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below